<DOC>
	<DOCNO>NCT01016548</DOCNO>
	<brief_summary>The purpose study determine whether adult hematologic malignancy active systemic therapy shortly bone marrow transplantation need one two dos adjuvanted vaccine achieve best possible rate protection . An additional research question whether baseline biomarkers cellular humoral immune system associate antibody response vaccination .</brief_summary>
	<brief_title>Evaluation Influenza H1N1 Vaccine Adults With Lymphoid Malignancies Chemotherapy</brief_title>
	<detailed_description>The novel influenza H1N1 virus responsible world-wide pandemic throughout 2009 ( H1N1 ( 2009 ) ) expect cause second wave infection 2009/10 winter season . Vaccines H1N1 ( 2009 ) available early November , 2009 . Adults hematologic disorder high risk influenza-related complication , include death . Given vaccination dose pandemic vaccine develop healthy individual , unknown whether subgroup patient respond similarly . We evaluate safety efficacy pandemic vaccine patient lymphoid malignancy receive active systemic treatment , recently undergone stem cell transplantation . Patients randomize one two dos approve adjuvanted vaccine ; immune response measure identify optimal regimen . Also , look association biomarkers immune system response vaccine ; do measure baseline CD3 , 4 , 8 , 19 , 56 cell flow cytometry .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male female , age 2065 Diagnosis lymphoproliferative disorder One follow type systemic treatment : active chemo/immunotherapy enrollment complete within last 3 month , OR auto/allo stem cell transplant recipient within past 12 month Able provide consent comply trial requirement Systemic hypersensitivity hen 's egg , thimerosal , gentamicin History lifethreatening reaction prior influenza vaccination Thrombocytopenia bleed disorder contraindicate IM injection Pregnancy Laboratoryconfirmed infection H1N1 ( 2009 ) IVIG infusion within last three month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Lymphoma</keyword>
	<keyword>Multiple myeloma</keyword>
	<keyword>Leukemia , Lymphocytic , Chronic , B-Cell</keyword>
	<keyword>Influenza A Virus , H1N1 Subtype</keyword>
	<keyword>Influenza Vaccines</keyword>
	<keyword>Bone Marrow Transplantation</keyword>
</DOC>